Merck Group reported Q2 profit after income tax of €494m, down from €655m a year earlier, and EPS fell to €1.13 from €1.50. Despite the decline, EBITDA pre grew organically 9.3% to €1.6bn, indicating some operational momentum. Net profitability weakened year-over-year, which is likely to temper near-term sentiment for the stock.
Merck Group reported Q2 profit after income tax of €494m, down from €655m a year earlier, and EPS fell to €1.13 from €1.50. Despite the decline, EBITDA pre grew organically 9.3% to €1.6bn, indicating some operational momentum. Net profitability weakened year-over-year, which is likely to temper near-term sentiment for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
